Mirabella Financial Services LLP Acquires New Holdings in The Beauty Health Company (NASDAQ:SKIN)

Mirabella Financial Services LLP bought a new stake in shares of The Beauty Health Company (NASDAQ:SKIN - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 8,988,571 shares of the company's stock, valued at approximately $14,292,000. Beauty Health comprises about 1.3% of Mirabella Financial Services LLP's holdings, making the stock its 14th largest position. Mirabella Financial Services LLP owned about 7.24% of Beauty Health at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of SKIN. Sanctuary Advisors LLC grew its holdings in shares of Beauty Health by 49.2% in the third quarter. Sanctuary Advisors LLC now owns 36,695 shares of the company's stock valued at $52,000 after acquiring an additional 12,103 shares in the last quarter. HighTower Advisors LLC purchased a new stake in shares of Beauty Health during the 3rd quarter valued at $121,000. SG Americas Securities LLC raised its stake in shares of Beauty Health by 38.2% during the 4th quarter. SG Americas Securities LLC now owns 35,290 shares of the company's stock worth $56,000 after purchasing an additional 9,749 shares during the period. Barclays PLC boosted its holdings in shares of Beauty Health by 224.7% in the 3rd quarter. Barclays PLC now owns 106,103 shares of the company's stock worth $153,000 after buying an additional 73,425 shares during the last quarter. Finally, Pilgrim Partners Asia Pte Ltd purchased a new position in shares of Beauty Health in the 4th quarter worth about $57,000. 93.26% of the stock is owned by hedge funds and other institutional investors.

Beauty Health Stock Performance

SKIN traded down $0.01 during trading hours on Friday, hitting $0.97. The stock had a trading volume of 148,980 shares, compared to its average volume of 1,103,611. The stock has a market cap of $121.49 million, a PE ratio of -2.31 and a beta of 0.84. The Beauty Health Company has a 1 year low of $0.78 and a 1 year high of $3.63. The company has a quick ratio of 5.57, a current ratio of 6.56 and a debt-to-equity ratio of 9.23. The company's fifty day simple moving average is $1.25 and its 200 day simple moving average is $1.48.

Beauty Health (NASDAQ:SKIN - Get Free Report) last posted its quarterly earnings results on Wednesday, March 12th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.10) by $0.02. The company had revenue of $83.50 million for the quarter, compared to analyst estimates of $78.02 million. Beauty Health had a negative net margin of 8.11% and a negative return on equity of 44.83%. During the same quarter in the previous year, the firm posted ($0.07) earnings per share. Equities analysts anticipate that The Beauty Health Company will post -0.25 earnings per share for the current year.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group lowered their price objective on shares of Beauty Health from $1.75 to $1.50 and set a "hold" rating on the stock in a research report on Thursday, March 13th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat.com, Beauty Health presently has an average rating of "Hold" and an average price target of $2.50.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.